AegirBio's CEO Marco Witteveen to Attend SalivaDirect's 3rd Annual Conference in Washington, DC, June 5-7, 2024

This prestigious 3-day event is tailored to foster dynamic discussions and collaborations, offering an ideal platform to exchange innovative ideas with some of the most brilliant minds in the industry. As attendee, AegirBio is eagerly anticipating the opportunity to gain insights from esteemed members of the company’s network and renowned leaders in the diagnostic world.

"We are excited to participate in SalivaDirect's 3rd Annual Conference," remarked Marco Witteveen. "This event presents an invaluable opportunity to engage in inspiring discussions with fellow laboratories, diagnostic developers, academics, and public health practitioners. Together, we aim to drive the industry forward and accelerate progress in infectious disease testing."

AegirBio looks forward to contributing to the vibrant dialogue and forging meaningful collaborations that will shape the future of diagnostic innovation and global health.

Datum 2024-05-29, kl 08:30
Källa Cision
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!